162 related articles for article (PubMed ID: 27558821)
1. Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity.
Frey B; Derer A; Scheithauer H; Wunderlich R; Fietkau R; Gaipl US
Adv Exp Med Biol; 2016; 930():151-72. PubMed ID: 27558821
[TBL] [Abstract][Full Text] [Related]
2. Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.
Frey B; Rubner Y; Wunderlich R; Weiss EM; Pockley AG; Fietkau R; Gaipl US
Curr Med Chem; 2012; 19(12):1751-64. PubMed ID: 22414083
[TBL] [Abstract][Full Text] [Related]
3. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.
Werthmöller N; Frey B; Rückert M; Lotter M; Fietkau R; Gaipl US
Int J Hyperthermia; 2016; 32(1):23-30. PubMed ID: 26754406
[TBL] [Abstract][Full Text] [Related]
4. Immunogenic Apoptotic Cell Death and Anticancer Immunity.
Vandenabeele P; Vandecasteele K; Bachert C; Krysko O; Krysko DV
Adv Exp Med Biol; 2016; 930():133-49. PubMed ID: 27558820
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation effects on the tumor microenvironment.
Portella L; Scala S
Semin Oncol; 2019 Jun; 46(3):254-260. PubMed ID: 31383368
[TBL] [Abstract][Full Text] [Related]
6. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
Garg AD; Agostinis P
Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
[TBL] [Abstract][Full Text] [Related]
7. Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies.
Rückert M; Deloch L; Fietkau R; Frey B; Hecht M; Gaipl US
Strahlenther Onkol; 2018 Jun; 194(6):509-519. PubMed ID: 29500551
[TBL] [Abstract][Full Text] [Related]
8. The changing paradigm of tumour response to irradiation.
Hill RP
Br J Radiol; 2017 Jan; 90(1069):20160474. PubMed ID: 27416998
[TBL] [Abstract][Full Text] [Related]
9. Kill and spread the word: stimulation of antitumor immune responses in the context of radiotherapy.
Gaipl US; Multhoff G; Scheithauer H; Lauber K; Hehlgans S; Frey B; Rödel F
Immunotherapy; 2014; 6(5):597-610. PubMed ID: 24896628
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
Walshaw RC; Honeychurch J; Illidge TM
Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
[TBL] [Abstract][Full Text] [Related]
12. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
[TBL] [Abstract][Full Text] [Related]
13. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
Chajon E; Castelli J; Marsiglia H; De Crevoisier R
Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
[TBL] [Abstract][Full Text] [Related]
14. The immunological consequences of radiation-induced DNA damage.
Wilkins AC; Patin EC; Harrington KJ; Melcher AA
J Pathol; 2019 Apr; 247(5):606-614. PubMed ID: 30632153
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy and immunogenic cell death.
Golden EB; Apetoh L
Semin Radiat Oncol; 2015 Jan; 25(1):11-7. PubMed ID: 25481261
[TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy and radiotherapy].
Bockel S; Antoni D; Deutsch É; Mornex F
Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
[TBL] [Abstract][Full Text] [Related]
17. Molecular characteristics of immunogenic cancer cell death.
Tesniere A; Panaretakis T; Kepp O; Apetoh L; Ghiringhelli F; Zitvogel L; Kroemer G
Cell Death Differ; 2008 Jan; 15(1):3-12. PubMed ID: 18007663
[TBL] [Abstract][Full Text] [Related]
18. A stochastic model for tumour control probability that accounts for repair from sublethal damage.
Ponce Bobadilla AV; Maini PK; Byrne H
Math Med Biol; 2018 Jun; 35(2):181-202. PubMed ID: 28339783
[TBL] [Abstract][Full Text] [Related]
19. Local tumour ablative therapies: opportunities for maximising immune engagement and activation.
O'Brien MA; Power DG; Clover AJ; Bird B; Soden DM; Forde PF
Biochim Biophys Acta; 2014 Dec; 1846(2):510-23. PubMed ID: 25286319
[TBL] [Abstract][Full Text] [Related]
20. Building immunity to cancer with radiation therapy.
Haikerwal SJ; Hagekyriakou J; MacManus M; Martin OA; Haynes NM
Cancer Lett; 2015 Nov; 368(2):198-208. PubMed ID: 25592036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
